VXA-CoV2-1

· Vaxart, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VXA-CoV2-1, covering 2024-06-21 to 2025-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine [Phase 2]